[HTML] sciencedirect.com

[HTML][HTML] Radioiodine therapy in advanced differentiated thyroid cancer: Resistance and overcoming strategy

Y Liu, J Wang, X Hu, Z Pan, T Xu, J Xu, L Jiang… - Drug Resistance …, 2023 - Elsevier
Thyroid cancer is the most prevalent endocrine tumor and its incidence is fast-growing
worldwide in recent years. Differentiated thyroid cancer (DTC) is the most common …
被引用次数：21 相关文章

Radioiodine therapy in advanced differentiated thyroid cancer: Resistance and overcoming strategy.

Y Liu, J Wang, X Hu, Z Pan, T Xu, J Xu… - … and Commentaries in …, 2023 - europepmc.org
Thyroid cancer is the most prevalent endocrine tumor and its incidence is fast-growing
worldwide in recent years. Differentiated thyroid cancer (DTC) is the most common …

Radioiodine therapy in advanced differentiated thyroid cancer: Resistance and overcoming strategy

Y Liu, J Wang, X Hu, Z Pan, T Xu… - Drug resistance …, 2023 - pubmed.ncbi.nlm.nih.gov
Thyroid cancer is the most prevalent endocrine tumor and its incidence is fast-growing
worldwide in recent years. Differentiated thyroid cancer (DTC) is the most common …